Akram Echtay

Insulin glargine versus sitagliptin in insulin-naive patients with type 2 diabetes mellitus uncontrolled on metformin (EASIE): a multicentre, randomised open-label trial

Pablo Aschner, Juliana C.N. Chan, David R. Owens et al. · The Lancet · 2012 · 110 citations

Metabolic Syndrome, Open-label Trial, Diabetes Management +7

The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: a randomised trial

Saud Al Sifri, A. Basiounny, Akram Echtay et al. · International Journal of Clinical Practice · 2011 · 105 citations · Full text

Metabolic Syndrome, Diabetes Management, Diabetes Epidemiology +11

The characteristics and pattern of care for the type 2 diabetes mellitus population in the MENA region during Ramadan: An international prospective study (DAR-MENA T2DM)

Mohamed Hassanein, Fatheya F. Al Awadi, Khaled El Sayed El Hadidy et al. · Diabetes Research and Clinical Practice · 2019 · 79 citations · Full text

Contribution of common variants of ENPP1, IGF2BP2, KCNJ11, MLXIPL, PPARγ, SLC30A8 and TCF7L2 to the risk of type 2 diabetes in Lebanese and Tunisian Arabs

Nabil Mtiraoui, Amira Turki, Rita Nemr et al. · Diabetes & Metabolism · 2012 · 61 citations

Metabolic Syndrome, Genetic Determinant, Diabetes Epidemiology +13

Tolerability of canagliflozin in patients with type 2 diabetes mellitus fasting during Ramadan: Results of the Canagliflozin in Ramadan Tolerance Observational Study (CRATOS)

Mohamed Hassanein, Akram Echtay, Ahmed Hassoun et al. · International Journal of Clinical Practice · 2017 · 53 citations · Full text